GLANDOSANE spray neutre 50 ml

7680384710158 CH-38471 A01AD11 12.99.0.

Reimbursement limitations:

BESTRAHLUNG

Lésions buccales à la suite de radiations / Syndrome de Sjögren

GLANDOSANE spray neutre 50 ml
GLANDOSANE spray neutre 50 ml
GLANDOSANE spray neutre 50 ml
1 / 3
google

Details

Product number
3847101
CPT
-
Packaging group
50
Unit
ml
Composition
kalii chloridum 1.2 mg, natrii chloridum 844 µg, magnesii chloridum hexahydricum 52 µg, calcii chloridum dihydricum 146 µg, dikalii phosphas anhydricus 342 µg, carmellosum natricum 10 mg, sorbitolum 30 mg, conserv.: E 200, E 211, aqua q.s. ad solutionem et propellentia ad aerosolum pro 1 g.

Articles (1)

Glandosane, Spray
Spray
50
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
1.2 MG Substance Wirkstoff (Principe actif)
(N/A)
844.0 UG Substance Wirkstoff (Principe actif)
(N/A)
52.0 UG Substance Wirkstoff (Principe actif)
(N/A)
146.0 UG Substance Wirkstoff (Principe actif)
(N/A)
342.0 UG Substance Wirkstoff (Principe actif)
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
30.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance TRGAS
(N/A)
0.5 MG Substance HBESI
(N/A)
0.59 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
38471
Drug name
Glandosane, Spray zur Anwendung in der Mundhöhle, Lösung
Galenic form
SPSL
ATC Code
A01AD11
Authorization status
Z
Dispensation category
D
First authorization
18/11/1977
Authorization expiration date
31/12/9999
IT number
12.99.0.
Domain
Human medicine
Field of application
Speichelersatz

Packaging details

Description (FR)
GLANDOSANE spray neutre 50 ml
Description (DE)
GLANDOSANE Spray neutral 50 ml
Market launch
18/11/1977
Narcotic (BTM)
No

Other packaging sizes

GLANDOSANE spray aromatisé 50 ml
50 ML
View